Hanchao Lin, Yixin Yu, Le Zhu, Nannan Lai, Luming Zhang, Yu Guo, Xinxin Lin, Dongqin Yang, Ning Ren, Zhiling Zhu, Qiongzhu Dong
Journal: Redox biology 2023;59():102601
PMID: 36630819
Hydrogen sulfide (HS) is an important signaling molecule in colorectal cancer (CRC). It is produced in the colon by the catalytic synthesis of the colonocytes' enzymatic systems and the release of intestinal microbes, and is oxidatively metabolized in the colonocytes' mitochondria. Both endogenous HS in colonic epithelial cells and exogenous HS in intestinal lumen contribute to the onset and progression of CRC. The up-regulation of endogenous synthetases is thought to be the cause of the elevated HS levels in CRC cells. Different diagnostic probes and combination therapies, as well as tumor treatment approaches through HS modulation, have been developed in recent years and have become active area of investigation for the diagnosis and treatment of CRC. In this review, we focus on the specific mechanisms of HS production and oxidative metabolism as well as the function of HS in the occurrence, progression, diagnosis, and treatment of CRC. We also discuss the present challenges and provide insights into the future research of this burgeoning field.
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.